A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis

200095 citationsJournal Article

Authors

Michael Davidson · Sheba Medical Center

Philip D. Harvey · Mount Sinai Hospital

J. Vervarcke

C. A. Gagiano · University of the Free State

J. D. De Hooge

Gary Bray · Sedgefield Community Hospital

M. Dose

Yoram Barak · Sheba Medical Center

Abstract

Long-term treatment with risperidone was associated with continued symptom improvement, a decrease in the severity of preexising EPS, and a low incidence of TD in elderly psychotic patients.

Topics & Keywords

Schizophrenia research and treatment Bipolar Disorder and Treatment Parkinson's Disease Mechanisms and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: International Journal of Geriatric Psychiatry

Volume 15, Issue 6, pp. 506-514

DOI: 10.1002/1099-1166(200006)15:6<506::aid-gps146>3.0.co;2-v

Field-Weighted Citation Impact: 6.84